Georgia-Vasiliki Gkountana

Georgia-Vasiliki Gkountana

Auto-generated profile, based on publicly available information

Georgia-Vasiliki Gkountana

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden https://ror.org/048a87296 https://www.isni.org/isni

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
IGIlias Giannakodimos
Ilias Giannakodimos
GGGeorgia-Vasiliki Gkountana
Georgia-Vasiliki Gkountana
Dimosthenis LykourasDimosthenis Lykouras
Dimosthenis Lykouras
KKKyriakos Karkoulias
Kyriakos Karkoulias
STSotiris Tsakas
Sotiris Tsakas
A newly identified virus appeared in Wuhan, China, in December 2019, was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and caused the coronavirus disease 2019 (COVID-19). SARS-CoV-2 presents similarities with two previous coronavirus pandemics, MERS (Middle East Respiratory Syndrome) and SARSCoV, concerning phylogenetic origin, structural composition, and clinical symptoms, thus, leading to common pathogenic mechanisms. The purpose of this review is to declare the role of interleukin-6 (IL-6) in the pathogenesis, prognosis, and treatment of COVID-19 by comparing its effect on SARS-CoV and MERS cases. Increased levels of IL-6 comprise the key for the stimulation of cytokine storm and the progression of SARS, MERS, and COVID-19 cases. Especially, in COVID-19 patients, the overactivation of NF-kΒ, which is caused by the binding of coronavirus spike protein S to alveolar epithelial cells, up-regulates IL-6 and promotes its systematic circulation, causing alveolar damage and extrapulmonary injury. Additionally, IL-6 can be used to evaluate respiratory failure and identify asymptomatic patients. Tocilizumab (TCZ), a monoclonal antibody which blocks IL-6 signaling, comprises a remedial option against COVID-19. TCZ improves oxygenation, reduces fever, and decreases levels of IL-6. IL-6 plays a major role in the pathogenesis of cytokine storm and the progression of COVID-19 and may be used as a therapeutic target against COVID-19. However, further research is needed concerning the relation of IL-6 in COVID-19 cases, and more clinical trials are required to declare TCZ as a treatment option.

16 April 2025 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
CTCarlos Enrique Torres-Méndez
Carlos Enrique Torres-Méndez
SNSharmilee Nandi
Sharmilee Nandi
KMKlara Martinovic
Klara Martinovic
PKPatrizia Kühne
Patrizia Kühne
YLYifan Liu
Yifan Liu
MKMasood Kamali-Moghaddam
Masood Kamali-Moghaddam
An electrochemical biosensor based on modified carbon screen-printed electrodes was developed for the detection of hemagglutinin of influenza A H1N1 virus (H1). Gold nanoflowers were electrodeposited on the electrode to increase conductivity and surface area. The electrochemical signal was amplified by functionalization of the gold nanoflowers with 4-aminothiophenol, which resulted in a 100-fold decrease of the charge transfer resistance due to a tunneling effect. Subsequently, monoclonal antibodies against H1 were immobilized on the surface via covalent amide bond formation, followed by blocking with bovine serum albumin to minimize nonspecific hydrophobic binding. The electrodes were characterized by cyclic voltammetry and electrochemical impedance spectroscopy experiments in the presence of [Fe(CN)6]3−/4−. Differential pulse voltammetry was used to measure the change in current across the electrode as a function of H1 concentration. This was performed on a series of samples of artificial saliva containing H1 protein in a clinically relevant concentration range. In these experiments, the biosensor showed a limit of detection of 19 pg/mL. Finally, the biosensor platform was coupled to an automated microfluidics system, and no significant decrease of the electrochemical signal was observed.

13 January 2025 in Beilstein Archives
Verified
Preprint
Open access
PDF file
CMCarlos Enrique Torres Méndez
Carlos Enrique Torres Méndez
SNSharmilee Nandi
Sharmilee Nandi
KMKlara Martinovic
Klara Martinovic
PKPatrizia Kühne
Patrizia Kühne
YLYifan Liu
Yifan Liu
MKMasood Kamali-Moghaddam
Masood Kamali-Moghaddam
An electrochemical biosensor based on modified carbon screen-printed electrodes (CSPE) was developed for the detection of hemagglutinin of influenza A H1N1 virus (H1). Gold nanoflowers were electrodeposited on the electrode to increase conductivity and surface area. The electrochemical signal was amplified by functionalization of the gold nanoflowers with 4-aminothiophenol, which resulted in a 100-fold decrease of the charge transfer resistance due to a tunneling effect. Subsequently, monoclonal antibodies against H1 were immobilized on the surface via covalent amide bond formation, followed by blocking with bovine serum albumin to minimize nonspecific hydrophobic binding. The electrodes were characterized by cyclic voltammetry and electrochemical impedance spectroscopy experiments in presence of [Fe(CN)6]3−/4−. Differential pulse voltammetry was used to measure the change in current across the electrode as a function of H1 concentration. This was performed on a series of samples of artificial saliva containing H1 protein in a clinically relevant concentration range. In these experiments, the biosensor showed a limit of detection of 19 pg/mL. Finally, the biosensor platform was coupled to an automated microfluidics system and no significant decrease of the electrochemical signal was observed.